These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10375401

  • 1. The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2.
    Zhou Y, Gottesman MM, Pastan I.
    Arch Biochem Biophys; 1999 Jul 01; 367(1):74-80. PubMed ID: 10375401
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Kinetic analyses for species differences in P-glycoprotein-mediated drug transport.
    Katoh M, Suzuyama N, Takeuchi T, Yoshitomi S, Asahi S, Yokoi T.
    J Pharm Sci; 2006 Dec 01; 95(12):2673-83. PubMed ID: 16892207
    [Abstract] [Full Text] [Related]

  • 8. Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein.
    Vahedi S, Lusvarghi S, Pluchino K, Shafrir Y, Durell SR, Gottesman MM, Ambudkar SV.
    Sci Rep; 2018 Aug 24; 8(1):12716. PubMed ID: 30143707
    [Abstract] [Full Text] [Related]

  • 9. Cysteine-scanning mutagenesis provides no evidence for the extracellular accessibility of the nucleotide-binding domains of the multidrug resistance transporter P-glycoprotein.
    Blott EJ, Higgins CF, Linton KJ.
    EMBO J; 1999 Dec 01; 18(23):6800-8. PubMed ID: 10581253
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
    Ruth A, Stein WD, Rose E, Roninson IB.
    Biochemistry; 2001 Apr 10; 40(14):4332-9. PubMed ID: 11284689
    [Abstract] [Full Text] [Related]

  • 16. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
    Graber-Maier A, Gutmann H, Drewe J.
    Mol Pharm; 2010 Oct 04; 7(5):1618-28. PubMed ID: 20701289
    [Abstract] [Full Text] [Related]

  • 17. MDR1 causes resistance to the antitumour drug miltefosine.
    Rybczynska M, Liu R, Lu P, Sharom FJ, Steinfels E, Pietro AD, Spitaler M, Grunicke H, Hofmann J.
    Br J Cancer; 2001 May 18; 84(10):1405-11. PubMed ID: 11355955
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution.
    Shaik N, Giri N, Pan G, Elmquist WF.
    Drug Metab Dispos; 2007 Nov 18; 35(11):2076-85. PubMed ID: 17709369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.